RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This trial will assess whether RGH patients who have two recurrent episodes within a three
month period would benefit from suppressive treatment and whether patients prefer episodic
therapy or suppressive therapy for the treatment of their RGH.